NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Troy,

BB is absolutely right on those predictions. Check the clinical trials on dendritic cells on clinicaltrials.gov. You can see researchers try dendritic cells on different targets: cancers, virus, bacteria, autoimmune diseases, and so on and so forth. I haven't seen any breakthrough except DCVax-L.

Think about this way. Human immune system can get rid of 99.99% of mutated cells automatically. The rest 0.01% are so smart and elusive that human immune system cannot catch them. When those mutated cells build stronghold and become tumors. Human immune system get along with those tumor cells. But the dendritic cells trained and educated by NWBO technology can recognize those tumor cells. This can tell us from one perspective how amazing DCVax-L is.

But don't forgot antiviral, bacteria, and autoimmune diseases. Anything that involves letting dendritic cells present something to the immune system, NWBO technology can find its use.